Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | cellular tumor antigen P53 | 0.0054 | 0.0063 | 0.0063 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0003 | 0.0003 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0015 | 0.0003 | 0.0003 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0033 | 0.0031 | 0.0031 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0038 | 0.0038 | 0.0038 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0015 | 0.0003 | 0.0003 |
Brugia malayi | Serine/threonine-protein kinase Pim-3 | 0.0821 | 0.1237 | 0.1237 |
Trichomonas vaginalis | set domain proteins, putative | 0.026 | 0.0378 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.0003 | 0.0003 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0027 | 0.0021 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0046 | 0.0052 | 0.0052 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0032 | 0.0029 | 0.0029 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0046 | 0.0052 | 0.0052 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0015 | 0.0003 | 0.0003 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.0821 | 0.1237 | 0.1237 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.6546 | 1 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0015 | 0.0003 | 0.0003 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0027 | 0.0021 | 1 |
Brugia malayi | hypothetical protein | 0.0027 | 0.0021 | 0.0021 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0029 | 0.0029 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0038 | 0.0038 | 0.0038 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.0821 | 0.1237 | 0.1237 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0027 | 0.0021 | 0.5 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0033 | 0.0031 | 1 |
Echinococcus multilocularis | tumor protein p63 | 0.037 | 0.0547 | 0.0547 |
Schistosoma mansoni | sodium-bile acid cotransporter related | 0.2655 | 0.4043 | 0.4043 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0027 | 0.0021 | 0.7021 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0033 | 0.0031 | 0.0031 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0821 | 0.1237 | 0.1237 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.0021 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.0038 | 1 |
Onchocerca volvulus | 0.0033 | 0.0031 | 0.0031 | |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0015 | 0.0003 | 0.0003 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0027 | 0.0021 | 0.7021 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0757 | 0.1138 | 0.1138 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.0003 | 0.0003 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0757 | 0.1138 | 0.1138 |
Brugia malayi | hypothetical protein | 0.0038 | 0.0038 | 0.0038 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0228 | 0.033 | 0.033 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0032 | 0.0029 | 0.0029 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.6546 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.0038 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.0003 | 0.0003 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0031 | 0.0031 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.0003 | 0.0003 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0757 | 0.1138 | 0.1138 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0038 | 0.0038 | 0.0038 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0015 | 0.0003 | 0.0003 |
Echinococcus multilocularis | proto oncogene serine:threonine protein kinase | 0.0821 | 0.1237 | 0.1237 |
Schistosoma mansoni | sodium-bile acid cotransporter | 0.3892 | 0.5937 | 0.5937 |
Brugia malayi | Pre-SET motif family protein | 0.0228 | 0.033 | 0.033 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0033 | 0.0031 | 0.0031 |
Onchocerca volvulus | Serine\/threonine protein kinase homolog | 0.0821 | 0.1237 | 0.1237 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0033 | 0.0031 | 0.0031 |
Onchocerca volvulus | 0.026 | 0.0378 | 0.0378 | |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.6546 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0017 | 0.0007 | 0.0007 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0033 | 0.0031 | 0.0031 |
Brugia malayi | Pre-SET motif family protein | 0.0033 | 0.0031 | 0.0031 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0046 | 0.0052 | 0.0052 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0015 | 0.0003 | 0.0003 |
Echinococcus multilocularis | GPCR, family 2 | 0.0015 | 0.0003 | 0.0003 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.6546 | 1 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0033 | 0.0031 | 0.0031 |
Schistosoma mansoni | sodium-bile acid cotransporter related | 0.6546 | 1 | 1 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.6546 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0021 | 0.0021 |
Echinococcus granulosus | proto oncogene serine:threonine protein kinase | 0.0821 | 0.1237 | 0.1237 |
Onchocerca volvulus | 0.0054 | 0.0063 | 0.0063 | |
Plasmodium vivax | SET domain protein, putative | 0.0033 | 0.0031 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0821 | 0.1237 | 0.1237 |
Onchocerca volvulus | 0.6546 | 1 | 1 | |
Leishmania major | hypothetical protein, conserved | 0.0027 | 0.0021 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.0038 | 1 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0033 | 0.0031 | 0.0031 |
Loa Loa (eye worm) | hypothetical protein | 0.6546 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0038 | 0.0038 | 1 |
Mycobacterium tuberculosis | Probable transmembrane multidrug efflux pump | 0.0013 | 0 | 0.5 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.6546 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0052 | 0.0052 |
Echinococcus granulosus | tumor protein p63 | 0.037 | 0.0547 | 0.0547 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.0038 | 0.0038 |
Echinococcus granulosus | GPCR family 2 | 0.0015 | 0.0003 | 0.0003 |
Schistosoma mansoni | hypothetical protein | 0.0032 | 0.0029 | 0.0029 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0027 | 0.0021 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.0063 | 0.0063 |
Chlamydia trachomatis | ABC transporter ATP binding protein/permease | 0.0013 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC20 (binding) | = 1.17 uM | Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells. | ChEMBL. | 10891114 |
IC50 (binding) | > 2.91 uM | Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells. | ChEMBL. | 10891114 |
MIC (functional) | = 0.4 ug ml-1 | Minimum growth-inhibitory concentration against S. cerevisiae ATCC 9763 by agar dilution method by the suspension of a fungi containing ~5 x 10e (7) cells/mL. | ChEMBL. | 10891114 |
Pgp AbA/analogue ratio (functional) | = 0.6 | Direct comparison of the antifungal activities with the relative Pgp-inhibitory potencies, calculated by comparing microg/mL IC50(or IC20). | ChEMBL. | 10891114 |
Pgp AbA/analogue ratio (functional) | = 1 | Relative Pgp inhibitory activity (in Human MDR1 cells) compared to AbA | ChEMBL. | 10891114 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.